4.2 Article

Deep Relaxation Experience with Complementary Urban Zen Integrative Therapy: Qualitative Thematic Analysis

Journal

WESTERN JOURNAL OF NURSING RESEARCH
Volume 43, Issue 8, Pages 723-731

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/0193945920973941

Keywords

Complementary Health Approach (CHA); Urban Zen Integrative Therapy (UZIT); Pulmonary Hypertension; mind-body intervention; relaxation response

Categories

Funding

  1. Sigma Theta Tau International Research Grant
  2. Ohio Nurses Foundation Research Grant
  3. Jonas Nurse Leadership Award
  4. Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [T32HP30035]

Ask authors/readers for more resources

The study examined the relaxation experience of patients with pulmonary hypertension during Urban Zen Integrative Therapy (UZIT) and found that deep relaxation was achieved primarily during body-awareness meditation and while drifting into an asleep state.
Complementary Health Approaches (CHAs) are used as adjunctive therapy for managing symptoms associated with chronic conditions. Little evidence exists about how patients with pulmonary hypertension use or experience CHA. We explored patients' relaxation experience during Urban Zen Integrative Therapy (UZIT) and present qualitative thematic analysis results of 32 focused-debriefing-interviews. Thirteen community-dwelling adults received six individual weekly sessions that included essential oil, gentle-body movement, restorative pose, body-awareness meditation, and Reiki. Two themes, Relaxation and In-between state, were subjected to dimensional analysis and detailed description. We identified conditions or phenomena contributing to these themes across the following contextual sub-categories: time/temporal, associated elements, what the experience felt like, and asleep state. Deep relaxation experience was achieved when participants lost the sense of time, primarily during body-awareness meditation, and while they were drifting into an asleep state. These elements provide clarity for the future development of therapeutic endpoints of patients' experience of CHA. ClinicalTrial.gov # NCT03194438

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available